1 Introduction to Research & Analysis Reports
1.1 Multi-ingredient Codeine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi-ingredient Codeine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi-ingredient Codeine Overall Market Size
2.1 Global Multi-ingredient Codeine Market Size: 2022 VS 2029
2.2 Global Multi-ingredient Codeine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Multi-ingredient Codeine Sales: 2018-2029
3 Company Landscape
3.1 Top Multi-ingredient Codeine Players in Global Market
3.2 Top Global Multi-ingredient Codeine Companies Ranked by Revenue
3.3 Global Multi-ingredient Codeine Revenue by Companies
3.4 Global Multi-ingredient Codeine Sales by Companies
3.5 Global Multi-ingredient Codeine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Multi-ingredient Codeine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Multi-ingredient Codeine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multi-ingredient Codeine Players in Global Market
3.8.1 List of Global Tier 1 Multi-ingredient Codeine Companies
3.8.2 List of Global Tier 2 and Tier 3 Multi-ingredient Codeine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Multi-ingredient Codeine Market Size Markets, 2022 & 2029
4.1.2 15mg
4.1.3 30mg
4.1.4 60mg
4.2 By Type – Global Multi-ingredient Codeine Revenue & Forecasts
4.2.1 By Type – Global Multi-ingredient Codeine Revenue, 2018-2023
4.2.2 By Type – Global Multi-ingredient Codeine Revenue, 2024-2029
4.2.3 By Type – Global Multi-ingredient Codeine Revenue Market Share, 2018-2029
4.3 By Type – Global Multi-ingredient Codeine Sales & Forecasts
4.3.1 By Type – Global Multi-ingredient Codeine Sales, 2018-2023
4.3.2 By Type – Global Multi-ingredient Codeine Sales, 2024-2029
4.3.3 By Type – Global Multi-ingredient Codeine Sales Market Share, 2018-2029
4.4 By Type – Global Multi-ingredient Codeine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Multi-ingredient Codeine Market Size, 2022 & 2029
5.1.2 Narcotic Analgesic
5.1.3 Antitussive
5.1.4 Others
5.2 By Application – Global Multi-ingredient Codeine Revenue & Forecasts
5.2.1 By Application – Global Multi-ingredient Codeine Revenue, 2018-2023
5.2.2 By Application – Global Multi-ingredient Codeine Revenue, 2024-2029
5.2.3 By Application – Global Multi-ingredient Codeine Revenue Market Share, 2018-2029
5.3 By Application – Global Multi-ingredient Codeine Sales & Forecasts
5.3.1 By Application – Global Multi-ingredient Codeine Sales, 2018-2023
5.3.2 By Application – Global Multi-ingredient Codeine Sales, 2024-2029
5.3.3 By Application – Global Multi-ingredient Codeine Sales Market Share, 2018-2029
5.4 By Application – Global Multi-ingredient Codeine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Multi-ingredient Codeine Market Size, 2022 & 2029
6.2 By Region – Global Multi-ingredient Codeine Revenue & Forecasts
6.2.1 By Region – Global Multi-ingredient Codeine Revenue, 2018-2023
6.2.2 By Region – Global Multi-ingredient Codeine Revenue, 2024-2029
6.2.3 By Region – Global Multi-ingredient Codeine Revenue Market Share, 2018-2029
6.3 By Region – Global Multi-ingredient Codeine Sales & Forecasts
6.3.1 By Region – Global Multi-ingredient Codeine Sales, 2018-2023
6.3.2 By Region – Global Multi-ingredient Codeine Sales, 2024-2029
6.3.3 By Region – Global Multi-ingredient Codeine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Multi-ingredient Codeine Revenue, 2018-2029
6.4.2 By Country – North America Multi-ingredient Codeine Sales, 2018-2029
6.4.3 US Multi-ingredient Codeine Market Size, 2018-2029
6.4.4 Canada Multi-ingredient Codeine Market Size, 2018-2029
6.4.5 Mexico Multi-ingredient Codeine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Multi-ingredient Codeine Revenue, 2018-2029
6.5.2 By Country – Europe Multi-ingredient Codeine Sales, 2018-2029
6.5.3 Germany Multi-ingredient Codeine Market Size, 2018-2029
6.5.4 France Multi-ingredient Codeine Market Size, 2018-2029
6.5.5 U.K. Multi-ingredient Codeine Market Size, 2018-2029
6.5.6 Italy Multi-ingredient Codeine Market Size, 2018-2029
6.5.7 Russia Multi-ingredient Codeine Market Size, 2018-2029
6.5.8 Nordic Countries Multi-ingredient Codeine Market Size, 2018-2029
6.5.9 Benelux Multi-ingredient Codeine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Multi-ingredient Codeine Revenue, 2018-2029
6.6.2 By Region – Asia Multi-ingredient Codeine Sales, 2018-2029
6.6.3 China Multi-ingredient Codeine Market Size, 2018-2029
6.6.4 Japan Multi-ingredient Codeine Market Size, 2018-2029
6.6.5 South Korea Multi-ingredient Codeine Market Size, 2018-2029
6.6.6 Southeast Asia Multi-ingredient Codeine Market Size, 2018-2029
6.6.7 India Multi-ingredient Codeine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Multi-ingredient Codeine Revenue, 2018-2029
6.7.2 By Country – South America Multi-ingredient Codeine Sales, 2018-2029
6.7.3 Brazil Multi-ingredient Codeine Market Size, 2018-2029
6.7.4 Argentina Multi-ingredient Codeine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Multi-ingredient Codeine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Multi-ingredient Codeine Sales, 2018-2029
6.8.3 Turkey Multi-ingredient Codeine Market Size, 2018-2029
6.8.4 Israel Multi-ingredient Codeine Market Size, 2018-2029
6.8.5 Saudi Arabia Multi-ingredient Codeine Market Size, 2018-2029
6.8.6 UAE Multi-ingredient Codeine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Taiji
7.1.1 Taiji Company Summary
7.1.2 Taiji Business Overview
7.1.3 Taiji Multi-ingredient Codeine Major Product Offerings
7.1.4 Taiji Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.1.5 Taiji Key News & Latest Developments
7.2 Mallinckrodt
7.2.1 Mallinckrodt Company Summary
7.2.2 Mallinckrodt Business Overview
7.2.3 Mallinckrodt Multi-ingredient Codeine Major Product Offerings
7.2.4 Mallinckrodt Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.2.5 Mallinckrodt Key News & Latest Developments
7.3 TEVA
7.3.1 TEVA Company Summary
7.3.2 TEVA Business Overview
7.3.3 TEVA Multi-ingredient Codeine Major Product Offerings
7.3.4 TEVA Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.3.5 TEVA Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Multi-ingredient Codeine Major Product Offerings
7.4.4 Johnson & Johnson Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Medreich
7.5.1 Medreich Company Summary
7.5.2 Medreich Business Overview
7.5.3 Medreich Multi-ingredient Codeine Major Product Offerings
7.5.4 Medreich Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.5.5 Medreich Key News & Latest Developments
7.6 Sanofi Aventis
7.6.1 Sanofi Aventis Company Summary
7.6.2 Sanofi Aventis Business Overview
7.6.3 Sanofi Aventis Multi-ingredient Codeine Major Product Offerings
7.6.4 Sanofi Aventis Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.6.5 Sanofi Aventis Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Multi-ingredient Codeine Major Product Offerings
7.7.4 Cipla Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Hikma
7.8.1 Hikma Company Summary
7.8.2 Hikma Business Overview
7.8.3 Hikma Multi-ingredient Codeine Major Product Offerings
7.8.4 Hikma Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.8.5 Hikma Key News & Latest Developments
7.9 Pharmaceutical Associates
7.9.1 Pharmaceutical Associates Company Summary
7.9.2 Pharmaceutical Associates Business Overview
7.9.3 Pharmaceutical Associates Multi-ingredient Codeine Major Product Offerings
7.9.4 Pharmaceutical Associates Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.9.5 Pharmaceutical Associates Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Multi-ingredient Codeine Major Product Offerings
7.10.4 Novartis Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Apotex
7.11.1 Apotex Company Summary
7.11.2 Apotex Multi-ingredient Codeine Business Overview
7.11.3 Apotex Multi-ingredient Codeine Major Product Offerings
7.11.4 Apotex Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.11.5 Apotex Key News & Latest Developments
7.12 Mylan
7.12.1 Mylan Company Summary
7.12.2 Mylan Multi-ingredient Codeine Business Overview
7.12.3 Mylan Multi-ingredient Codeine Major Product Offerings
7.12.4 Mylan Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.12.5 Mylan Key News & Latest Developments
7.13 Aristo Pharma GmbH
7.13.1 Aristo Pharma GmbH Company Summary
7.13.2 Aristo Pharma GmbH Multi-ingredient Codeine Business Overview
7.13.3 Aristo Pharma GmbH Multi-ingredient Codeine Major Product Offerings
7.13.4 Aristo Pharma GmbH Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.13.5 Aristo Pharma GmbH Key News & Latest Developments
7.14 Lannett Company
7.14.1 Lannett Company Company Summary
7.14.2 Lannett Company Business Overview
7.14.3 Lannett Company Multi-ingredient Codeine Major Product Offerings
7.14.4 Lannett Company Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.14.5 Lannett Company Key News & Latest Developments
7.15 Laboratoire Riva
7.15.1 Laboratoire Riva Company Summary
7.15.2 Laboratoire Riva Business Overview
7.15.3 Laboratoire Riva Multi-ingredient Codeine Major Product Offerings
7.15.4 Laboratoire Riva Multi-ingredient Codeine Sales and Revenue in Global (2018-2023)
7.15.5 Laboratoire Riva Key News & Latest Developments
8 Global Multi-ingredient Codeine Production Capacity, Analysis
8.1 Global Multi-ingredient Codeine Production Capacity, 2018-2029
8.2 Multi-ingredient Codeine Production Capacity of Key Manufacturers in Global Market
8.3 Global Multi-ingredient Codeine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multi-ingredient Codeine Supply Chain Analysis
10.1 Multi-ingredient Codeine Industry Value Chain
10.2 Multi-ingredient Codeine Upstream Market
10.3 Multi-ingredient Codeine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multi-ingredient Codeine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の多成分コデイン市場予測2023-2029：15mg、30mg、60mg |
| 【英語タイトル】Multi-ingredient Codeine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5783 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：111 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の多成分コデイン市場規模と予測を収録しています。・世界の多成分コデイン市場：売上、2018年-2023年、2024年-2029年 ・世界の多成分コデイン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の多成分コデイン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「15mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 多成分コデインのグローバル主要企業は、Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Rivaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、多成分コデインのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の多成分コデイン市場：タイプ別、2018年-2023年、2024年-2029年 世界の多成分コデイン市場：タイプ別市場シェア、2022年 ・15mg、30mg、60mg 世界の多成分コデイン市場：用途別、2018年-2023年、2024年-2029年 世界の多成分コデイン市場：用途別市場シェア、2022年 ・麻薬性鎮痛薬、鎮咳薬、その他 世界の多成分コデイン市場：地域・国別、2018年-2023年、2024年-2029年 世界の多成分コデイン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における多成分コデインのグローバル売上、2018年-2023年 ・主要企業における多成分コデインのグローバル売上シェア、2022年 ・主要企業における多成分コデインのグローバル販売量、2018年-2023年 ・主要企業における多成分コデインのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Riva ************************************************************* ・調査・分析レポートの概要 多成分コデイン市場の定義 市場セグメント 世界の多成分コデイン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の多成分コデイン市場規模 世界の多成分コデイン市場規模：2022年 VS 2029年 世界の多成分コデイン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの多成分コデインの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の多成分コデイン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：15mg、30mg、60mg 多成分コデインのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：麻薬性鎮痛薬、鎮咳薬、その他 多成分コデインの用途別グローバル売上・予測 ・地域別市場分析 地域別多成分コデイン市場規模 2022年と2029年 地域別多成分コデイン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Taiji、 Mallinckrodt、 TEVA、 Johnson & Johnson、 Medreich、 Sanofi Aventis、 Cipla、 Hikma、 Pharmaceutical Associates、 Novartis、 Apotex、 Mylan、 Aristo Pharma GmbH、 Lannett Company、 Laboratoire Riva ... |
Multi-ingredient Codeine means the drugs contain codeine and another ingredient.
This report aims to provide a comprehensive presentation of the global market for Multi-ingredient Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-ingredient Codeine. This report contains market size and forecasts of Multi-ingredient Codeine in global, including the following market information:
Global Multi-ingredient Codeine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Multi-ingredient Codeine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Multi-ingredient Codeine companies in 2022 (%)
The global Multi-ingredient Codeine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
15mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multi-ingredient Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multi-ingredient Codeine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multi-ingredient Codeine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Multi-ingredient Codeine Market Segment Percentages, by Type, 2022 (%)
15mg
30mg
60mg
Global Multi-ingredient Codeine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Multi-ingredient Codeine Market Segment Percentages, by Application, 2022 (%)
Narcotic Analgesic
Antitussive
Others
Global Multi-ingredient Codeine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Multi-ingredient Codeine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multi-ingredient Codeine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Multi-ingredient Codeine revenues share in global market, 2022 (%)
Key companies Multi-ingredient Codeine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Multi-ingredient Codeine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multi-ingredient Codeine, market overview.
Chapter 2: Global Multi-ingredient Codeine market size in revenue and volume.
Chapter 3: Detailed analysis of Multi-ingredient Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-ingredient Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Multi-ingredient Codeine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の多成分コデイン市場予測2023-2029：15mg、30mg、60mg] (コード：MMG23JU5783)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の多成分コデイン市場予測2023-2029：15mg、30mg、60mg]についてメールでお問い合わせ |
